5 years of historical data (2020–2024) · Healthcare · Medical - Devices
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Hyperion DeFi, Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Market Cap | $3M | — | — | — | — | — |
| Enterprise Value | $12M | — | — | — | — | — |
| P/E Ratio → | -0.06 | — | — | — | — | — |
| P/S Ratio | 51.87 | — | — | — | — | — |
| P/B Ratio | — | — | — | — | — | — |
| P/FCF | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| EV / Revenue | — | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Hyperion DeFi, Inc. earns an operating margin of -85004.6%. Operating margins have expanded from -670885.8% to -85004.6% over the past 3 years, signaling improving operational efficiency.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Gross Margin | -6749.5% | -6749.5% | -322.6% | — | 88.6% | 60.0% |
| Operating Margin | -85004.6% | -85004.6% | -670885.8% | — | -93.0% | -989.5% |
| Net Profit Margin | -86888.6% | -86888.6% | -719859.9% | — | -91.3% | -988.5% |
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| ROE | — | — | -207.8% | -148.6% | -71.4% | -129.2% |
| ROA | -307.1% | -307.1% | -91.2% | -89.4% | -39.0% | -58.3% |
| ROIC | -1168.9% | -1168.9% | -258.8% | -319.1% | — | — |
| ROCE | -1418.8% | -1418.8% | -111.0% | -114.5% | -71.9% | -126.0% |
Solvency and debt-coverage ratios — lower is generally safer
Net debt stands at $9M ($11M total debt minus $2M cash).
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Debt / Equity | — | — | 1.79 | 0.59 | 0.35 | 0.03 |
| Debt / EBITDA | — | — | — | — | — | — |
| Net Debt / Equity | — | — | 0.14 | -0.74 | -0.60 | -1.82 |
| Net Debt / EBITDA | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — |
| Interest Coverage | -19.62 | -19.62 | -10.71 | -19.50 | -33.58 | -1161.20 |
Short-term solvency ratios and asset-utilisation metrics
The current ratio of 0.17x is below 1.0, meaning current liabilities exceed current assets. The current ratio has declined from 6.13x to 0.17x over the past 3 years.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Current Ratio | 0.17 | 0.17 | 2.17 | 6.13 | 1.97 | 1.83 |
| Quick Ratio | 0.17 | 0.17 | 2.16 | 6.13 | 1.97 | 1.83 |
| Cash Ratio | 0.13 | 0.13 | 1.56 | 5.07 | 1.74 | 1.56 |
| Asset Turnover | — | 0.02 | 0.00 | — | 0.44 | 0.06 |
| Inventory Turnover | — | — | 0.15 | — | — | — |
| Days Sales Outstanding | — | 158.05 | 11935.32 | — | 47.06 | 541.30 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Hyperion DeFi, Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — |
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — |
| Buyback Yield | 0.0% | — | — | — | — | — |
| Total Shareholder Yield | 0.0% | — | — | — | — | — |
| Shares Outstanding | — | $832997 | $512912 | $420621 | $329051 | $263184 |
Compare HYPD with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| $3M | -0.1 | — | — | -6749.5% | -85004.6% | — | -1168.9% | — | |
| $51B | 43.4 | 29.3 | 21.0 | 74.6% | 20.0% | 10.1% | 5.7% | 4.8 | |
| $60B | -11.8 | — | — | 68.7% | -1140.8% | -11.6% | -9.9% | — | |
| $69B | 37.2 | 36.6 | 42.3 | 83.3% | 46.8% | 22.0% | 7.9% | 7.1 | |
| $8B | 53.2 | 34.7 | 27.1 | 23.6% | 10.0% | 15.3% | 11.7% | 0.2 | |
| $114B | -55.3 | 193.6 | — | 1.9% | 0.9% | -11.9% | 9.2% | 8.8 | |
| $5B | -3.4 | — | — | -47.7% | -90.6% | -34.5% | -9.0% | — | |
| $9B | -12.4 | — | — | -15.6% | -61.8% | -22.1% | -8.7% | — | |
| $11B | -47.3 | — | — | -614.6% | -2104.6% | -16.9% | -13.8% | — | |
| $4B | 12.5 | 6.5 | — | 41.6% | 41.6% | 18.5% | 10.3% | 1.2 | |
| $589M | 9.2 | 8.5 | — | 61.9% | 16.8% | 9.2% | 6.5% | 0.2 | |
| Healthcare Median | — | 22.3 | 14.4 | 18.5 | 63.9% | -5.2% | -33.7% | -11.2% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Includes 30+ ratios · 5 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationSide-by-side business, growth, and profitability comparison vs Coinbase Global, Inc..
Start ComparisonQuick answers to the most common questions about buying HYPD stock.
Hyperion DeFi, Inc.'s current P/E ratio is -0.1x. This places it at the 50th percentile of its historical range.
Based on historical data, Hyperion DeFi, Inc. is trading at a P/E of -0.1x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Hyperion DeFi, Inc. has -6749.5% gross margin and -85004.6% operating margin.